-

11:05:56 AM

GMED Stock News

GMED - Globus Medical Inc

05/15/23 4:30 PM

NYSE : GMED

fda approval

Globus Medical Announces FDA Approval for its Non-Fusion Scoliosis Correction System, the Latest Advancement for Young Patients with Idiopathic Scoliosis

Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the REFLECT ™ Scoliosis Correction System has been granted approval from the

RHEA-AI

neutral

05/04/23 4:15 PM

NYSE : GMED

earnings

Globus Medical Reports First Quarter 2023 Results

Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended March 31, 2023. Worldwide net sales were $276.7 million, an increase of 20.0%, or 21.0% on a constant currency

RHEA-AI

neutral

04/27/23 7:08 PM

NYSE : GMED

acquisition

Globus Medical Shareholders Approve Share Issuance for Merger with NuVasive

Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced that at the special meeting of shareholders held earlier today its shareholders voted to approve the issuance of shares of Globus Medical Class A common

RHEA-AI

neutral

04/27/23 11:30 AM

Nasdaq, NYSE : NUVA, GMED

acquisition

NuVasive Shareholders Approve Merger Agreement with Globus Medical

NuVasive, Inc., the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced that at the special meeting of shareholders held earlier today, its shareholders voted to approve the adoption of the Company's merger agreement with Globus Medical.

RHEA-AI

neutral

04/19/23 5:15 PM

NYSE : GMED

earnings

Globus Medical Schedules First Quarter Earnings Release and Conference Call

Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended March 31, 2023 after the market close on Thursday, May 4, 2023. A copy of the release will be available

RHEA-AI

neutral

04/17/23 1:57 PM

Nasdaq, NYSE : NUVA, GMED

acquisition

Leading Independent Proxy Advisory Firm Glass Lewis Joins ISS in Recommending NuVasive Shareholders Vote "FOR" the Proposed Merger with Globus Medical

NuVasive, Inc., the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced that proxy advisory firm, Glass Lewis& Co., LLC, recommends that NuVasive shareholders vote "FOR" the shareholder proposal to adopt the merger agreement with Globus Medical at...

RHEA-AI

positive

04/14/23 2:21 PM

Nasdaq, NYSE : NUVA, GMED

acquisition

Leading Independent Proxy Advisory Firm ISS Recommends NuVasive Shareholders Vote "FOR" the Proposed Merger with Globus Medical

NuVasive, Inc., the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced that leading independent proxy advisory firm Institutional Shareholder Services recommends that NuVasive shareholders vote "FOR" the shareholder proposal to adopt the merger...

RHEA-AI

positive

02/21/23 4:15 PM

NYSE : GMED

Globus Medical Reports Fourth Quarter and Full Year 2022 Results

Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2022. Fourth Quarter 2022: Worldwide net sales were $274.5 million, an increase

RHEA-AI

very positive

02/09/23 7:00 AM

Nasdaq, NYSE : NUVA, GMED

Globus Medical and NuVasive to Combine in All-Stock Transaction to Create Innovative Global Musculoskeletal Company Focused on Patient Care

Capitalizes on complementary global commercial organizations and accelerates Globus Medical's and NuVasive's globalization strategies to increase customer reach and deepen surgeon relationshipsBrings together innovative technologies to create comprehensive procedural solutions offering to better

RHEA-AI

very positive

02/02/23 4:30 PM

NYSE : GMED

earnings

Globus Medical Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call

Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year ended December 31, 2022 after the market close on Tuesday, February 21, 2023. A copy of the

RHEA-AI

neutral

GMED Data

IndustrySurgical and Medical Instrument Manufacturing
Websiteglobusmedical.com
CeoDavid Demski
Security nameGlobus Medical Inc - Class A
Issue typecs
SectorManufacturing
Sic code3841
Employees2600
Tags
- Health Technology
- Medical Specialties
- Manufacturing
- Surgical and Medical Instrument Manufacturing
Address2560 General Armistead Ave
StatePennsylvania
CityAudubon
Zip19403-5214
CountryUnited States
Phone16109301800

About Globus Medical Inc

globus medical, inc. is a leading musculoskeletal implant manufacturer and is driving significant technological advancements across a complete suite of spinal products. founded in 2003, globus’ single-minded focus on advancing spinal surgery has made it the fastest growing company in the history of orthopedics. globus is driven to utilize superior engineering and technology to achieve pain free, active lives for all patients with spinal disorders. additional information can be accessed at www.globusmedical.com.